Evidence map›Paper›PMID 37551315›Full record

ArticleAsian biomedicine : research, reviews and news2022

Prevalence and management of eosinophilia based on periodic health examinations in primary care clinics.

Thareerat Ananchaisarp, Panya Chamroonkiadtikun, Jakrawadee Julamanee, Kewalee Perdvong, Thitawan Chimpalee, Nutnicha Rattanavirakul, Nattawat Leelarujijaroen, Tiprada Hathaipitak, Thanarat Tantinam

Registry-linked trialAbstract read
In one paragraph

Article in Asian biomedicine : research, reviews and news, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06265870 (Comparison of Outcome Between Specific Anthelminthic Treatment According to Test Results and Empirical Anthelminthic Treatment in Eosinophilic Patient), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06265870 narecruitingnot on this mapstarted 2024, after this paper: background citation

Comparison of Outcome Between Specific Anthelminthic Treatment According to Test Results and Empirical Anthelminthic Treatment in Eosinophilic Patient

TypeinterventionalSponsorPrince of Songkla UniversityRan2024 to 2025Enrolled700ConditionsEosinophiliaArmsAlbendazole, Ivermectin or albendazole
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Thareerat AnanchaisarpDivision of Family and Preventive Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand.ORCID https://orcid.org/0000-0002-3386-242X
Panya ChamroonkiadtikunDivision of Family and Preventive Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand.ORCID https://orcid.org/0000-0001-5821-4739
Jakrawadee JulamaneeDivision of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand.ORCID https://orcid.org/0000-0002-6526-9479
Kewalee PerdvongFaculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand.ORCID https://orcid.org/0000-0002-7048-5846
Thitawan ChimpaleeFaculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand.ORCID https://orcid.org/0000-0001-5876-014X
Nutnicha RattanavirakulFaculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand.ORCID https://orcid.org/0000-0002-2315-6345
Nattawat LeelarujijaroenFaculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand.ORCID https://orcid.org/0000-0001-5470-2786
Tiprada HathaipitakFaculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand.ORCID https://orcid.org/0000-0001-9997-5235
Thanarat TantinamFaculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand.ORCID https://orcid.org/0000-0002-1134-8972

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Eosinophilia is a common, hematologic abnormality detected in periodic health checkups with diverse etiologies. There are a few clinical practice guidelines for the management of eosinophilia. Objectives: To determine the prevalence of eosinophilia among patients undergoing periodic health examinations, evaluate its management and outcomes, and identify its associated factors. Methods: We conducted a retrospective study that included patients with eosinophilia diagnosed during the 2018 periodic health examinations at Songklanagarind Hospital. Results: The prevalence rate of eosinophilia was 9.6% (988/10,299), and most patients (52.6%) were male with a median age of 53.0 (42.0-61.0) years. Only 174 patients (17.6%) were diagnosed and further examined to identify the cause of eosinophilia; including an examination of medical history (18.4%), physical examination (93.1%), laboratory analysis (9.2%), and consultation with internists (14.9%). Empirical anthelmintic therapy was administered in 130 patients (74.7%), and 49.2% achieved resolution. The possible causes of eosinophilia were identified in 20.7% (204/988), the most common cause being atopic disease (51.5%). Patients with moderate-to-severe eosinophilia were significantly more likely to be diagnosed, undergo further laboratory tests, and proceed with consultations with internists (adjusted OR [95% CI] = 3.52 [1.97-6.32], 17.13 [5.74-51.11], and 6.38 [1.95-20.93], respectively). Conclusions: Eosinophilia is commonly identified in periodic health examinations, and most primary physicians lack knowledge regarding the diagnostic work-up required to determine the cause of eosinophilia. Empirical anthelmintic therapy showed satisfactory efficacy for the management of eosinophilia in areas where parasite infection is endemic.

Indexed as

anthelminticeosinophiliaperiodic health examinationsprevalencetherapeutics

Identifiers

PMID37551315
PMCPMC10321192

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.